Page 40 - Anjali Singh

Classic Legends to invest Rs 1,000 cr in 3 years to increase production

Mahindra group Chairman Anand Mahindra said the bikes belonged to the 'classic retro' segment, which had a growing customer base

IndiaRF invests Rs 525 crore in Ivy Health and Life Sciences Private Ltd

Financial advisors for this transaction included O3 Capital, representing IndiaRF, and Unaprime Investment Advisors, advising Ivy

Piramal Pharma is aiming to achieve zero waste to landfill by FY25

To achieve zero waste to landfill by FY2025, the company is taking a number of measures, including installing solvent recovery plants at its API and chemical plants

Abbott recalls antacid Digene Gel made in Goa after consumer complaints

India's drugs regulator issues advisory against use; company says there is no 'health concern'

TVS Motor eyes European market with launch of new Apache RTR 310 bike

Priced at Rs 2.42 lakh, the bike has been positioned competitively considering its BMW counterpart costs Rs 2.85 lakh

10-12% price hike in commercial vehicles likely: Credit rating agency Icra

There are a number of proposed regulatory changes that could further increase the cost of CVs

Apollo Hospitals to have 3,000 beds under real-time patient monitoring

This care technology, underpinned by artificial intelligence (AI), also monitors and detects early signs of patient deterioration, enabling timely corrective action

New Covid-19 variants causing global surges, but severity of infection down

In Southeast Asia, Thailand recorded highest number of fresh infections, followed by India where cases increased 2%

Planning to open manufacturing facility in Russia soon: Trivitron Group CEO

Apart from our joint venture in Russia, we are investing heavily in the US, where we already have infrastructure, including factories and R&D setups, said Ganjoo

Cabinet okays Rs 5k cr PRIP scheme to boost research and innovation

The scheme is set to stimulate collaboration between pharmaceutical companies, Cabinet greenlights Rs 5,000 crore PRIP scheme to boost research and innovation institutions, and start-ups

Volkswagen eyes for 95% localisation of components for Virtus, Taigun

In the second quarter of this year, Volkswagen Passenger Cars India, like others in the industry, encountered supply shortages due to global component issues

Raymond Group's Singhania takes on Maserati on safety, performance

Singhania also criticised the carmaker for failing to return his representatives' calls for over a week, questioning the level of customer service provided

French carmaker Renault looks to drive electric car into India next year

Renault India is actively working on a number of new models, including two internal combustion engine (ICE) products. The company had previously hinted at plans for an A-segment electric car

GS Design to remodel cars into luxury vehicles, says Gautam Singhania

Singhania said unlike traditional restoration facilities that often take years to complete projects, GS Design will deliver the car within three months with full restoration

Dr Agarwal's Health Care raises Rs 650 crore from TPG and Temasek

In addition, Dr Agarwal's Health Care has plans to invest around Rs 1,200 crore to establish hospitals across its regions in India and Africa

Just 7% Indians want doctors to prescribe only generic drugs: Survey

60% respondents wanted doctors to mention names of both branded drug and generic version

Hospital revenues to grow 8-10% in FY24 on rise in lifestyle disease: ICRA

The rating agency expects the aggregate occupancy for its hospital industry's sample set to remain strong at 60-65 per cent in FY24, building on the prior year's 65.1 per cent

Gujarat hosts first WHO Traditional Medicine Global Summit under G20 Meet

The meeting will see participation from various stakeholders, including 167 private hospitals, 125 medical facilitators, and 64 government hospitals

Glenmark Pharma Q1 results: Profit after tax dips 22% to Rs 149.9 cr

Sequentially, the company exhibited a 0.8 per cent increase in revenue and managed to turn around the PAT, having reported a loss of Rs 428.3 crore in the previous quarter

New Omicron sub-variant spreads in UK; no reported case in India so far

UK health agency says no indication that EG.5.1 is more severe than the others; WHO advises countries to remain cautious